Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of LVAD Index With Selected Hepatic and Renal Biochemical Markers and Rehospitalization in HVAD and HeartMate 3 Continuous-Flow Left Ventricular Assist Devices

NCT07633535 is registered in ClinicalTrials.gov with Gaziantep City Hospital as lead sponsor.

NCT NCT07633535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07633535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of LVAD Index With Selected Hepatic and Renal Biochemical Markers and Rehospitalization in HVAD and HeartMate 3 Continuous-Flow Left Ventricular Assist Devices
Lead sponsor
Gaziantep City Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2022
Completion date
April 30, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage heart failure, left ventricular assist device, mechanical circulatory support